Dec 9, 2020 | Digital Dermatopathology, Digital Pathology, Press Release
Darren Whittemore, DO, joins the PathologyWatch team to support the delivery of optimal patient outcomes.
SALT LAKE CITY—DECEMBER 8, 2020—PathologyWatch, a full-service digital dermatopathology solution, is pleased to welcome Dr. Darren Whittemore, DO, to the growing PathologyWatch family. A qualified and respected dermatopathologist, Whittemore will be instrumental in establishing processes to ensure dermatology clinics receive the highest level of digital pathology services.
Board certified in anatomic and clinical pathology and dermatopathology, Whittemore was fellowship-trained at the University of Texas Health Science Center after completing his residency at the combined US Air Force Wilford Hall Medical Center/Brooke Army Medical Center program.
“Dermatopathologists play a critical role in a patient’s recommended treatment,” said Dan Lambert, CEO and cofounder of PathologyWatch. “With expertise and attention to detail, Dr. Whittemore utilizes innovative advances in digital pathology to deliver the highest quality of care and efficiency to patients.”
Whittemore brings extensive subspecialty experience and proven abilities in diagnosing alopecia cases to PathologyWatch. Also, he embraces new technologies and the growing role they play in understanding the pathogenesis of diseases.
“With advantages that include enhanced clinicopathologic correlation, improved turnaround time and paperless, electronic workflows, digital dermatopathology represents the future of the dermatology industry,” Whittemore said. “Joining PathologyWatch places me in the heart of this burgeoning technology with individuals who are committed to helping dermatology clinics deliver industry-leading care to their patients.”
For more information on PathologyWatch, please visit pathologywatch.com.
About PathologyWatch
PathologyWatch is the groundbreaking leader of digital dermatopathology services. Through these services, dermatology clinics, hospitals and laboratories can improve operational efficiency by speeding up workflow and enhancing patient outcomes by utilizing the PathologyWatch expert professional team and partner laboratory services. This can facilitate best-in-class reads and, in some cases, enable additional revenue to the practice by in-housing pathology. With an intuitive and easy-to-implement digital pathology solution that includes access to top-tier dermatopathologists and a streamlined clinical workflow that interfaces directly into the EMR, PathologyWatch brilliantly combines state-of-the-art technology and clinical decision-making to deliver unprecedented patient care.
View the original release.
Sep 10, 2020 | Press Release
Full-service lab PathologyWatch now provides remote, academic-level dermatopathology services to laboratories in need of temporary or long-term support.
SALT LAKE CITY (PRWEB) SEPTEMBER 10, 2020
Digital dermatopathology service provider PathologyWatch is now offering top-tier dermatopathology services to laboratories in need of temporary or long-term locum tenens support. Utilizing the advantages of digital pathology, PathologyWatch provides instant remote access to a workforce of academic-level dermatopathologists.
Commonly, a laboratory in need of locum tenens assistance is responsible for providing travel arrangements, lodging and per diem to attract qualified talent. Using an integrated digital pathology system, PathologyWatch eliminates costly overhead by offering a network of expert dermatopathologists available 24/7 for consultation. As a result, laboratories find a seamless transition to help them to continue running at full capacity.
“Providing locum tenens support to companies experiencing overflow due to staffing or seasonal variables is the next logical step for PathologyWatch,” says CEO and co-founder Dan Lambert. “Our locums tenens support is ideal for pathology labs and dermatology clinics that have a limited number of in-house dermatopathologists. The on-demand services require no minimum or advanced notice. When dermatopathologists have an influx of samples, have a life event, or even want to take a vacation, they can simply turn on the services for as long as they need them.”
In addition to a significant reduction in travel costs, PathologyWatch provides labs with 24/7 digital access to all pathology slides without purchasing a scanner. This also includes improved access to subspecialists and second opinions. Meanwhile, extensive insurance coverage means PathologyWatch can accommodate the majority of laboratory customers nationwide.
“Using PathologyWatch for locums coverage has given me access to high-quality dermatopathologists when I needed the coverage with ease and flexibility,” said Emily Green, dermatopathology lab director at Golden State Dermatology. “I highly recommend their services.”
For more information on PathologyWatch, please visit PathologyWatch.com. PathologyWatch follows all state and federal regulations. As such, the specific coverage arrangement may vary from state to state.
About PathologyWatch
PathologyWatch is the groundbreaking leader of digital dermatopathology services. Through these services, dermatology clinics, hospitals and laboratories can improve operational efficiency by speeding up workflow and enhance patient outcomes by utilizing the PathologyWatch expert professional team and partner laboratory services. This can facilitate best-in-class reads and, in some cases, enable additional revenue to the practice by in-housing pathology. With an intuitive and easy-to-implement digital pathology solution that includes access to top-tier dermatopathologists and a streamlined clinical workflow that interfaces directly into the EMR, PathologyWatch brilliantly combines state-of-the-art technology and clinical decision making to deliver unprecedented patient care.
May 12, 2020 | Press Release
Funding Led by SpringTide Investments and Rock Creek Capital
SALT LAKE CITY, MAY 11, 2020—PathologyWatch announced today a $5M series A funding led by SpringTide Investments and Rock Creek Capital with additional funding by individual investors. PathologyWatch is emerging as the groundbreaking leader of intuitive, easy-to-implement digital dermatopathology solutions that can speed the diagnostic process while reducing costs to clinics and enhancing patient care.
PathologyWatch will utilize this series A funding to strengthen outreach to dermatology clinics nationwide. Over 12 months, it expects to triple its sales force while expanding marketing efforts and implementing a strong channel partner strategy. The funding also represents a continued investment in the development of technology and supervised artificial intelligence (AI) for various cancer lines.
PathologyWatch differentiates itself from competitors by offering fully interfaced EMR (Electronic Medical Records) reporting and 24/7 access to digital slides. Clients also have access to top dermatopathologists and the option to interpret and bill for their cases. PathologyWatch is further distinct by its primary focus on outpatient clinics.
Changing “How Pathology Operates by Transforming Biopsy Diagnostics”
“We believe PathologyWatch will change how pathology operates by transforming biopsy diagnostics,” said Austin Waters, principal at SpringTide Investments. “PathologyWatch has created a platform to digitize pathology workflows and is a leading developer of AI algorithms that detect and characterize cancers from biopsy samples. The quality and breadth of their solution, and their early success in dermatopathology, is why we’re bullish on the future of this company; PathologyWatch is redefining biopsy diagnostics as we know it.”
First Live Clinical Implementation of Dermatopathology AI with Ability to Generate Complete Reports
“We have the first live clinical implementation of dermatopathology AI that can generate a full report and make physicians significantly more efficient in Australia, as we’re working alongside physicians to better diagnose skin cancer,” said PathologyWatch co-founder and CEO Dan Lambert.
Benefits the Patient by Merging Clinical Observations with Pathology
“PathologyWatch is a game changer,” said Jeffrey Smith, Dermatologist, Prairie Lakes Healthcare System. “Digital access to my cases, expert dermpath reads, and an EMR interface– not to mention the time savings and increase in revenue for our hospital, all while keeping our patients in-network. Most importantly, this benefits the patient by merging clinical observations with pathology.”*
The “Future of Dermatopathology for Dermatologists”
“I believe PathologyWatch is the future of dermatopathology for dermatologists. The group combines academic expertise with the efficiency of a private lab. It is a huge timesaver for me and my staff,” said April Larson, Dermatologist. “By reviewing my own cases, I am able to make better clinical decisions for my patients. It’s a win-win for everybody.”
For more information on PathologyWatch, please visit pathologywatch.com.
About PathologyWatch
PathologyWatch is the groundbreaking leader of digital dermatopathology services. Through two programs, ValueWatch and BusinessWatch, dermatology clinics and hospitals can improve operational efficiency by speeding up workflow and improve patient outcomes by utilizing the PathologyWatch expert professional team and partner laboratory services. This can facilitate best-in-class reads and, in some cases, enable additional revenue to the practice by in-housing pathology.* With an intuitive and easy-to-implement digital pathology solution that includes access to top-tier dermatopathologists and a streamlined clinical workflow that interfaces directly into the EMR, PathologyWatch brilliantly combines state-of-the-art technology and clinical decision making to deliver unprecedented patient care.
About SpringTide Investments
SpringTide is a network of experienced healthcare founders, operators, and investors in the healthcare space. With over $350M in collective exits across 4 startup companies, our Managing Partners are driven to provide access and support for fellow entrepreneurs who are expanding access to quality healthcare.
About Rock Creek Capital
A venture and equity investment firm, Rock Creek Capital is a Utah-based fund. Focused on growth equity, the fund helps entrepreneurs and founders of companies scale successfully.
